ResMed’s strong demand for AirSense 11 boosts its earnings outlook. Learn why RMD stock is undervalued with growth ...

Resmed has its origins in the 1980s, when Sydney sleep expert Dr Colin Sullivan converted a vacuum cleaner to deal with the ...

Brett Fishbin; Analyst; KeyBanc Capital Markets Inc. Welcome to the Q2 fiscal-year 2025 ResMed earnings conference call ... reflecting the continuing demand for our AirSense 10 and AirSense 11 ...

Q2 2025 Earnings Call Transcript January 30, 2025 ResMed Inc. beats earnings expectations. Reported EPS is $2.43, expectations were $2.32. Operator: Welcome to the Q2 Fiscal Year 2025 ResMed Earnings ...

CEO Michael Farrell reported 10% global revenue growth ... comfort and potentially redefining market standards for CPAP masks. ResMed also collaborated with Apple Vision Pro to introduce the ...

Q2 2025 Management View CEO Michael Farrell reported 10% global revenue growth, driven by demand across the sleep health, breathing health, and residential care software portfolios. Device sales, ...

Its core business includes the development of devices for sleep apnea -- such as CPAP ... ResMed’s intention to provide integrated patient care solutions and expand its market reach. ResMed's 10 ...

The company's revenue for the period rose 10.3% to $1.282 billion from $1.162 billion last year. Resmed Inc earnings at a glance (GAAP) : -Earnings: $344.6 Mln. vs. $208.6 Mln. last year.

CSL Ltd (ASX: CSL) and ResMed Inc (ASX: RMD ... Robust Continuous Airway Pressure Therapy (CPAP) patient growth assisted by growing awareness on Obstructive Sleep Apnea (OSA), (2) Market share ...

This country research report on Vietnam BiPAP Machine Market offers comprehensive insights into the market landscape, customer intelligence, and competitive strategies in the Vietnam market. The ...

In January 2024 , ResMed launched a new version of its AirSense 11 CPAP device, featuring an improved algorithm for pressure delivery and a more intuitive user interface. This innovation aims to ...